Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis
Abstract
:1. Introduction
2. Methods
2.1. Meta-Analysis
2.1.1. Eligibility Criteria
2.1.2. Information Sources and Search Methods
2.1.3. Study Selection, Data Collection, Summary Measures, and Individual Study Bias Assessment
2.1.4. Synthesis of Results
2.2. Pharmacoeconomic Analysis
3. Results
3.1. Study Selection and Characteristics
3.2. Clinical Outcomes
3.3. Non-Clinical Outcomes
3.4. Pharmacoeconomic Analyses
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Saunders, J.; Smith, T. Malnutrition: Causes and Consequences. Clin. Med. 2010, 10, 624–627. [Google Scholar] [CrossRef]
- Correia, M.I.T.D.; Perman, M.I.; Waitzberg, D.L. Hospital Malnutrition in Latin America: A Systematic Review. Clin. Nutr. 2017, 36, 958–967. [Google Scholar] [CrossRef] [PubMed]
- Singer, P.; Blaser, A.R.; Berger, M.M.; Alhazzani, W.; Calder, P.C.; Casaer, M.P.; Hiesmayr, M.; Mayer, K.; Montejo, J.C.; Pichard, C.; et al. ESPEN Guideline on Clinical Nutrition in the Intensive Care Unit. Clin. Nutr. Edinb. Scotl. 2019, 38, 48–79. [Google Scholar] [CrossRef]
- Mayer, K.; Schaefer, M.B.; Hecker, M. Intravenous N-3 Fatty Acids in the Critically Ill. Curr. Opin. Clin. Nutr. Metab. Care 2019, 22, 124–128. [Google Scholar] [CrossRef] [PubMed]
- Mayer, K.; Klek, S.; García-de-Lorenzo, A.; Rosenthal, M.D.; Li, A.; Evans, D.C.; Muscaritoli, M.; Martindale, R.G. Lipid Use in Hospitalized Adults Requiring Parenteral Nutrition. J. Parenter. Enter. Nutr. 2020, 44, S28–S38. [Google Scholar] [CrossRef]
- Raman, M.; Almutairdi, A.; Mulesa, L.; Alberda, C.; Beattie, C.; Gramlich, L. Parenteral Nutrition and Lipids. Nutrients 2017, 9, 388. [Google Scholar] [CrossRef]
- Calder, P.C.; Adolph, M.; Deutz, N.E.; Grau, T.; Innes, J.K.; Klek, S.; Lev, S.; Mayer, K.; Michael-Titus, A.T.; Pradelli, L.; et al. Lipids in the Intensive Care Unit: Recommendations from the ESPEN Expert Group. Clin. Nutr. 2018, 37, 1–18. [Google Scholar] [CrossRef]
- Waitzberg, D.L.; Torrinhas, R.S.; Jacintho, T.M. New Parenteral Lipid Emulsions for Clinical Use. J. Parenter. Enter. Nutr. 2006, 30, 351–367. [Google Scholar] [CrossRef]
- Calder, P.C. Use of Fish Oil in Parenteral Nutrition: Rationale and Reality. Proc. Nutr. Soc. 2006, 65, 264–277. [Google Scholar] [CrossRef] [PubMed]
- Calder, P.C.; Waitzberg, D.L.; Klek, S.; Martindale, R.G. Lipids in Parenteral Nutrition: Biological Aspects. J. Parenter. Enter. Nutr. 2020, 44. [Google Scholar] [CrossRef]
- Martindale, R.G.; Berlana, D.; Boullata, J.I.; Cai, W.; Calder, P.C.; Deshpande, G.H.; Evans, D.; Garcia-de-Lorenzo, A.; Goulet, O.J.; Li, A.; et al. Summary of Proceedings and Expert Consensus Statements From the International Summit “Lipids in Parenteral Nutrition”. J. Parenter. Enter. Nutr. 2020, 44. [Google Scholar] [CrossRef]
- Serhan, C.N. Pro-Resolving Lipid Mediators Are Leads for Resolution Physiology. Nature 2014, 510, 92–101. [Google Scholar] [CrossRef] [PubMed]
- Bird, J.K.; Troesch, B.; Warnke, I.; Calder, P.C. The Effect of Long Chain Omega-3 Polyunsaturated Fatty Acids on Muscle Mass and Function in Sarcopenia: A Scoping Systematic Review and Meta-Analysis. Clin. Nutr. ESPEN 2021, 46, 73–86. [Google Scholar] [CrossRef]
- McGlory, C.; Calder, P.C.; Nunes, E.A. The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease. Front. Nutr. 2019, 6, 144. [Google Scholar] [CrossRef]
- Williams, J.; Tu, S.; Lodhia, C.; Gu, G.; Haar, G.; O’Connor, J.; Niewiadomski, O.; Tandiari, T.; Nicoll, A.J. Parenteral Nutrition: How Do Patients Initiated in the Intensive Care Unit Differ from Those on the Ward? Clin. Nutr. Exp. 2019, 24, 72–76. [Google Scholar] [CrossRef]
- Weimann, A.; Braga, M.; Carli, F.; Higashiguchi, T.; Hübner, M.; Klek, S.; Laviano, A.; Ljungqvist, O.; Lobo, D.N.; Martindale, R.G.; et al. ESPEN Practical Guideline: Clinical Nutrition in Surgery. Clin. Nutr. 2021, 40, 4745–4761. [Google Scholar] [CrossRef]
- Pradelli, L.; Mayer, K.; Klek, S.; Omar Alsaleh, A.J.; Clark, R.A.C.; Rosenthal, M.D.; Heller, A.R.; Muscaritoli, M. Ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. J. Parenter. Enter. Nutr. 2020, 44, 44–57. [Google Scholar] [CrossRef]
- Pradelli, L.; Klek, S.; Mayer, K.; Omar Alsaleh, A.J.; Rosenthal, M.D.; Heller, A.R.; Muscaritoli, M. Omega-3 Fatty Acid-Containing Parenteral Nutrition in ICU Patients: Systematic Review with Meta-Analysis and Cost-Effectiveness Analysis. Crit. Care 2020, 24, 634. [Google Scholar] [CrossRef]
- PROSPERO International Register of Prospective Systematic Reviews. PROSPERO 2021 CRD42021293972. Available online: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021293972 (accessed on 1 April 2025).
- Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gotzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: Explanation and Elaboration. BMJ 2009, 339, b2700. [Google Scholar] [CrossRef]
- Higgins, J.P.; Green, S. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series; John Wiley & Sons Ltd.: Hoboken, NJ, USA, 2008. [Google Scholar]
- PRISMA-P Group; Moher, D.; Shamseer, L.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 Statement. Syst. Rev. 2015, 4, 1. [Google Scholar] [CrossRef]
- Mitchell, M.; Muftakhidinov, B.; Winchen, T.; Wilms, A.; van Schaik, B.; Badger, T.G.; Jędrzejewski-Szmek, Z. Engauge Digitizer Software 2020. Available online: https://sourceforge.net/projects/digitizer/ (accessed on 27 March 2025).
- Wan, X.; Wang, W.; Liu, J.; Tong, T. Estimating the Sample Mean and Standard Deviation from the Sample Size, Median, Range and/or Interquartile Range. BMC Med. Res. Methodol. 2014, 14, 135. [Google Scholar] [CrossRef]
- Aliyazicioglu, T.; Cantürk, N.Z.; Şimşek, T.; Kolayli, F.; Çekmen, M. Effects of Standard and/or Glutamine Dipeptide and/or Omega-3 Fatty Acid-Supplemented Parenteral Nutrition on Neutrophil Functions, Interleukin-8 Level, and Length of Stay: A Double-Blind, Controlled, Randomized Study. East Afr. Med. J. 2013, 90, 59–66. [Google Scholar] [PubMed]
- Al-Leswas, D.; Eltweri, A.M.; Chung, W.-Y.; Arshad, A.; Stephenson, J.A.; Al-Taan, O.; Pollard, C.; Fisk, H.L.; Calder, P.C.; Garcea, G.; et al. Intravenous Omega-3 Fatty Acids Are Associated with Better Clinical Outcome and Less Inflammation in Patients with Predicted Severe Acute Pancreatitis: A Randomised Double Blind Controlled Trial. Clin. Nutr. 2020, 39, 2711–2719. [Google Scholar] [CrossRef] [PubMed]
- Badía-Tahull, M.B.; Llop-Talaverón, J.M.; Leiva-Badosa, E.; Biondo, S.; Farran-Teixidó, L.; Ramón-Torrell, J.M.; Jódar-Masanes, R. A Randomised Study on the Clinical Progress of High-Risk Elective Major Gastrointestinal Surgery Patients Treated with Olive Oil-Based Parenteral Nutrition with or without a Fish Oil Supplement. Br. J. Nutr. 2010, 104, 737–741. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.; Pan, D.; Li, L. The Effects of Multi-Oil Fat Emulsion on Older Patients with Gastric Cancer. Biomed Res 2017, 28, 4270–4276. [Google Scholar]
- Demirer, S.; Sapmaz, A.; Karaca, A.S.; Kepenekci, I.; Aydintug, S.; Balci, D.; Sonyurek, P.; Kose, K. Effects of Postoperative Parenteral Nutrition with Different Lipid Emulsions in Patients Undergoing Major Abdominal Surgery. Ann. Surg. Treat. Res. 2016, 91, 309. [Google Scholar] [CrossRef]
- Flores-López, A.; Guevara-Cruz, M.; Avila-Nava, A.; González-Garay, A.G.; González-Salazar, L.E.; Reyes-Ramírez, A.L.; Pedraza-Chaverri, J.; Medina-Campos, O.N.; Medina-Vera, I.; Reyes-García, J.G.; et al. N-3 Polyunsaturated Fatty Acid Supplementation Affects Oxidative Stress Marker Levels in Patients with Type II Intestinal Failure: A Randomized Double Blind Trial. Antioxidants 2023, 12, 1493. [Google Scholar] [CrossRef]
- Ge, X.; Liu, H.; Wu, Y.; Liu, W.; Qi, W.; Ye, L.; Cao, Q.; Lian, H.; Bai, R.; Zhou, W. Parenteral n–3 Polyunsaturated Fatty Acids Supplementation Improves Postoperative Recovery for Patients with Crohn’s Disease after Bowel Resection: A Randomized, Unblinded Controlled Clinical Trial. Am. J. Clin. Nutr. 2024, 119, 1027–1035. [Google Scholar] [CrossRef]
- Grimm, H.; Mertes, N.; Goeters, C.; Schlotzer, E.; Mayer, K.; Grimminger, F.; Fürst, P. Improved Fatty Acid and Leukotriene Pattern with a Novel Lipid Emulsion in Surgical Patients. Eur. J. Nutr. 2006, 45, 55–60. [Google Scholar] [CrossRef]
- Hallay, J.; Olah, A.V.; Fulesdi, B.; Kocsor, M.; Vegh, T.; Kovacs, G.; Takacs, I.; Sapy, P.; Nagy, D.; Telessy, I.G. Hepatobiliary Response in Postoperative Lipid Therapy in Gastrointestinal Surgery. Hepatogastroenterology 2010, 57, 1069–1073. [Google Scholar]
- Jiang, Z.M.; Wilmore, D.W.; Wang, X.R.; Wei, J.M.; Zhang, Z.T.; Gu, Z.Y.; Wang, S.; Han, S.M.; Jiang, H.; Yu, K. Randomized Clinical Trial of Intravenous Soybean Oil Alone versus Soybean Oil plus Fish Oil Emulsion after Gastrointestinal Cancer Surgery. Br. J. Surg. 2010, 97, 804–809. [Google Scholar] [CrossRef] [PubMed]
- Klek, S.; Kulig, J.; Szczepanik, A.M.; Jedrys, J.; Kotodziejczyk, P. The Clinical Value of Parenteral Immunonutrition in Surgical Patients. Acta Chir. Belg. 2005, 105, 175–179. [Google Scholar] [CrossRef]
- Klek, S.; Kulig, J.; Sierzega, M.; Szybinski, P.; Szczepanek, K.; Kubisz, A.; Kowalczyk, T.; Gach, T.; Pach, R.; Szczepanik, A.M. The Impact of Immunostimulating Nutrition on Infectious Complications After Upper Gastrointestinal Surgery: A Prospective, Randomized, Clinical Trial. Ann. Surg. 2008, 248, 212–220. [Google Scholar] [CrossRef] [PubMed]
- Klek, S.; Sierzega, M.; Szybinski, P.; Szczepanek, K.; Scislo, L.; Walewska, E.; Kulig, J. Perioperative Nutrition in Malnourished Surgical Cancer Patients–A Prospective, Randomized, Controlled Clinical Trial. Clin. Nutr. 2011, 30, 708–713. [Google Scholar] [CrossRef] [PubMed]
- Köller, M. Impact of Omega-3 Fatty Acid Enriched TPN on Leukotriene Synthesis by Leukocytes after Major Surgery. Clin. Nutr. 2003, 22, 59–64. [Google Scholar] [CrossRef]
- Liang, B.; Wang, S.; Ye, Y.-J.; Yang, X.-D.; Wang, Y.-L.; Qu, J.; Xie, Q.-W.; Yin, M.-J. Impact of Postoperative Omega-3 Fatty Acid-Supplemented Parenteral Nutrition on Clinical Outcomes and Immunomodulations in Colorectal Cancer Patients. World J. Gastroenterol. 2008, 14, 2434. [Google Scholar] [CrossRef]
- Linseisen, J.; Hoffmann, J.; Lienhard, S.; Jauch, K.-W.; Wolfram, G. Antioxidant Status of Surgical Patients Receiving TPN with an Ω-3-Fatty Acid-Containing Lipid Emulsion Supplemented with α-Tocopherol. Clin. Nutr. 2000, 19, 177–184. [Google Scholar] [CrossRef]
- Ma, C.; Sun, L.; Chen, F.; Lu, C.; Shih, Y.; Tsai, H.; Chuang, J.; Wang, J. A Double-Blind Randomized Study Comparing the Efficacy and Safety of a Composite vs a Conventional Intravenous Fat Emulsion in Postsurgical Gastrointestinal Tumor Patients. Nutr. Clin. Pract. 2012, 27, 410–415. [Google Scholar] [CrossRef]
- Ma, C.-J.; Wu, J.-M.; Tsai, H.-L.; Huang, C.-W.; Lu, C.-Y.; Sun, L.-C.; Shih, Y.-L.; Chen, C.-W.; Chuang, J.-F.; Wu, M.-H.; et al. Prospective Double-Blind Randomized Study on the Efficacy and Safety of an n-3 Fatty Acid Enriched Intravenous Fat Emulsion in Postsurgical Gastric and Colorectal Cancer Patients. Nutr. J. 2015, 14, 9. [Google Scholar] [CrossRef]
- Makay, O.; Kaya, T.; Firat, O.; Sozbilen, M.; Caliskan, C.; Gezer, G.; Uyar, M.; Ersin, S. Ω-3 Fatty Acids Have No Impact on Serum Lactate Levels After Major Gastric Cancer Surgery. J. Parenter. Enter. Nutr. 2011, 35, 488–492. [Google Scholar] [CrossRef]
- Mertes, N.; Grimm, H.; Fürst, P.; Stehle, P. Safety and Efficacy of a New Parenteral Lipid Emulsion (SMOFlipid) in Surgical Patients: A Randomized, Double-Blind, Multicenter Study. Ann. Nutr. Metab. 2006, 50, 253–259. [Google Scholar] [CrossRef] [PubMed]
- Schauder, P.; Röhn, U.; Schäfer, G.; Korff, G.; Schenk, H.-D. Impact of Fish Oil Enriched Total Parenteral Nutrition on DNA Synthesis, Cytokine Release and Receptor Expression by Lymphocytes in the Postoperative Period. Br. J. Nutr. 2002, 87, S103–S110. [Google Scholar] [CrossRef]
- Senkal, M.; Geier, B.; Hannemann, M.; Deska, T.; Linseisen, J.; Wolfram, G.; Adolph, M. Supplementation of Ω-3 Fatty Acids in Parenteral Nutrition Beneficially Alters Phospholipid Fatty Acid Pattern. J. Parenter. Enter. Nutr. 2007, 31, 12–17. [Google Scholar] [CrossRef]
- Wang, J.; Yu, J.-C.; Kang, W.-M.; Ma, Z.-Q. Superiority of a Fish Oil–Enriched Emulsion to Medium-Chain Triacylglycerols/Long-Chain Triacylglycerols in Gastrointestinal Surgery Patients: A Randomized Clinical Trial. Nutrition 2012, 28, 623–629. [Google Scholar] [CrossRef]
- Wei, Z.; Wang, W.; Chen, J.; Yang, D.; Yan, R.; Cai, Q. A Prospective, Randomized, Controlled Study of ω-3 Fish Oil Fat Emulsion-Based Parenteral Nutrition for Patients Following Surgical Resection of Gastric Tumors. Nutr. J. 2014, 13, 25. [Google Scholar] [CrossRef] [PubMed]
- Wu, M.; Wang, M.; Yang, C.; Kuo, M.; Lin, M. Randomized Clinical Trial of New Intravenous Lipid (SMOFlipid 20%) Versus Medium-Chain Triglycerides/Long-Chain Triglycerides in Adult Patients Undergoing Gastrointestinal Surgery. J. Parenter. Enter. Nutr. 2014, 38, 800–808. [Google Scholar] [CrossRef]
- Zhang, B.; Wei, G.; Li, R.; Wang, Y.; Yu, J.; Wang, R.; Xiao, H.; Wu, C.; Leng, C.; Zhang, B.; et al. N-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients with Liver Cancer: A Randomized Controlled Clinical Trial. Clin. Nutr. 2017, 36, 1239–1244. [Google Scholar] [CrossRef] [PubMed]
- Zhixue, G.; Changqing, G.; Bing, H.; Zengwang, Q.; Yanjie, K.; Ya, Z.; Weihong, W.; Liqing, T.; Xin, F.; Xiaoyong, M.; et al. Effects of Parenteral Nutrition of ω-3 Polyunsaturated Fatty Acid, Arginine and Glutamine on Cellular Immune Status of Patients Following Liver Cancer Surgery. Trop. J. Pharm. Res. 2018, 17, 507. [Google Scholar] [CrossRef]
- Zhu, M.-W.; Tang, D.-N.; Hou, J.; Wei, J.-M.; Hua, B.; Sun, J.-H.; Cui, H.-Y. Impact of Fish Oil Enriched Total Parenteral Nutrition on Elderly Patients after Colorectal Cancer Surgery. Chin. Med. J. 2012, 125, 178–181. [Google Scholar]
- Zhu, X.; Wu, Y.; Qiu, Y.; Jiang, C.; Ding, Y. Effect of Parenteral Fish Oil Lipid Emulsion in Parenteral Nutrition Supplementation Combined With Enteral Nutrition Support in Patients Undergoing Pancreaticoduodenectomy. J. Parenter. Enter. Nutr. 2013, 37, 236–242. [Google Scholar] [CrossRef]
- Notz, Q.; Lee, Z.-Y.; Menger, J.; Elke, G.; Hill, A.; Kranke, P.; Roeder, D.; Lotz, C.; Meybohm, P.; Heyland, D.K.; et al. Omega-6 Sparing Effects of Parenteral Lipid Emulsions—An Updated Systematic Review and Meta-Analysis on Clinical Outcomes in Critically Ill Patients. Crit. Care 2022, 26, 23. [Google Scholar] [CrossRef] [PubMed]
- Wei, C.; Hua, J.; Bin, C.; Klassen, K. Impact of Lipid Emulsion Containing Fish Oil on Outcomes of Surgical Patients: Systematic Review of Randomized Controlled Trials from Europe and Asia. Nutrition 2010, 26, 474–481. [Google Scholar] [CrossRef] [PubMed]
- Chen, B.; Zhou, Y.; Yang, P.; Wan, H.; Wu, X. Safety and Efficacy of Fish Oil–Enriched Parenteral Nutrition Regimen on Postoperative Patients Undergoing Major Abdominal Surgery: A Meta-Analysis of Randomized Controlled Trials. J. Parenter. Enter. Nutr. 2010, 34, 387–394. [Google Scholar] [CrossRef]
- Pradelli, L.; Mayer, K.; Muscaritoli, M.; Heller, A.R. Correction: N-3 Fatty Acid-Enriched Parenteral Nutrition Regimens in Elective Surgical and ICU Patients: A Meta-Analysis. Crit. Care 2012, 17, 405. [Google Scholar] [CrossRef]
- Palmer, A.J.; Ho, C.K.M.; Ajibola, O.; Avenell, A. The Role of ω-3 Fatty Acid Supplemented Parenteral Nutrition in Critical Illness in Adults: A Systematic Review and Meta-Analysis. Crit. Care Med. 2013, 41, 307–316. [Google Scholar] [CrossRef]
- Li, N.-N.; Zhou, Y.; Qin, X.-P.; Chen, Y.; He, D.; Feng, J.-Y.; Wu, X.-T. Does Intravenous Fish Oil Benefit Patients Post-Surgery? A Meta-Analysis of Randomised Controlled Trials. Clin. Nutr. 2014, 33, 226–239. [Google Scholar] [CrossRef] [PubMed]
- Manzanares, W.; Langlois, P.L.; Dhaliwal, R.; Lemieux, M.; Heyland, D.K. Intravenous Fish Oil Lipid Emulsions in Critically Ill Patients: An Updated Systematic Review and Meta-Analysis. Crit. Care 2015, 19, 167. [Google Scholar] [CrossRef]
- Bae, H.J.; Lee, G.Y.; Seong, J.-M.; Gwak, H.S. Outcomes with Perioperative Fat Emulsions Containing Omega-3 Fatty Acid: A Meta-Analysis of Randomized Controlled Trials. Am. J. Health. Syst. Pharm. 2017, 74, 904–918. [Google Scholar] [CrossRef]
- Kreymann, K.G.; Heyland, D.K.; De Heer, G.; Elke, G. Intravenous Fish Oil in Critically Ill and Surgical Patients–Historical Remarks and Critical Appraisal. Clin. Nutr. 2018, 37, 1075–1081. [Google Scholar] [CrossRef]
- Xu, X.-T.; Huang, H.; Tian, M.-X.; Hu, R.-C.; Dai, Z.; Jin, X. A Four-Oil Intravenous Lipid Emulsion Improves Markers of Liver Function, Triglyceride Levels and Shortens Length of Hospital Stay in Adults: A Systematic Review and Meta-Analysis. Nutr. Res. 2021, 92, 1–11. [Google Scholar] [CrossRef]
- Pradelli, L.; Muscaritoli, M.; Klek, S.; Martindale, R.G. Pharmacoeconomics of Parenteral Nutrition with Ω-3 Fatty Acids in Hospitalized Adults. J. Parenter. Enter. Nutr. 2020, 44, S68–S73. [Google Scholar] [CrossRef]
Study | Country | Patient Type (n a) | PN Type | Intervention b | Comparator | Clinical Outcomes c | Laboratory Outcomes |
---|---|---|---|---|---|---|---|
Aliyazicioglu et al., 2013 [25] | UK | Colorectal cancer surgery (n = 36) | total | Standard TPN/FO (FO: 0.10–0.20 g/kg/day; % DLD not available) | Standard TPN | HLOS | – |
Al Leswas et al., 2020 [26] | Turkey | Severe acute pancreatitis(n = 45) | total | SO/MCT/FO (FO: 0.20 g/kg/day; 10% DLD) | SO/MCT | Mortality, infections, HLOS, and sepsis | CRP, DHA, EPA, and TNF |
Badia-Tahull et al., 2010 [27] | Spain | Major intestinal surgery (n = 29) | PN | SO/OO/FO (FO: 0.12–0.17 g/kg/day; 16.6% DLD) | SO/OO | Mortality, infections, HLOS, and sepsis | ALT, Cr, CRP, GGT, and PU |
Chen et al., 2017 [28] | China | Gastric cancer surgery (n = 120) | PN | SO/MCT/OO/FO (FO: 0.15 g/kg/day; 15% DLD) | SO | Infections and HLOS | ALT, bilirubin, CRP, and IL-6 |
Demirer et al., 2016 [29] | Turkey | Major abdominal surgery (n = 52) | PN | SO/OO/FO (FO dose not available; 15% DLD) | SO/OO or SO/MCT | – | CRP, IL-6, and TNF |
Flores-López et al., 2023 [30] | Mexico | Intestinal failure (n = 20) | total | SO/OO + FO (FO: 0.1–0.2 g/kg/day) | SO/OO | Mortality, infections, HLOS, and sepsis | – |
Ge et al., 2024 [31] | China | Major abdominal surgery (n = 268) | total | MCT/LCT + FO (FO: 0.2 g/kg/day) | MCT/LCT | Mortality, infections, HLOS, and sepsis | CRP, IL-6, and TNF |
Grimm et al., 2006 [32] | Germany | Major abdominal surgery (n = 33) | total | SO/MCT/OO/FO (FO: 0.23 g/kg/day; 15% DLD) | SO | HLOS | alpha-T, DHA, EPA, LTB4, LTB5, and LTB ratio |
Hallay et al., 2010 [33] | Hungary | Gastrointestinal surgery (n = 41) | total | SO/MCT/OO/FO(FO: 0.21 g/kg/day; 15% DLD) | SO/MCT | – | ALT, AST, bilirubin, and GGT |
Jiang et al., 2010 [34] | China | Gastrointestinal cancer surgery (n = 206) | PN | SO/FO (FO: 0.2 g/kg/day; 17% DLD) | SO | Infections, HLOS, and sepsis | Cr, IL-6, and TNF |
Klek et al., 2005 [35] | Poland | Gastric cancer surgery (n = 105, enrolled; n = 71, included in our analysis) | PN | SO/MCT/FO (FO: 0.10 g/kg/day; % DLD not available) | SO/MCT | Infections and HLOS | ALT, AST, Cr, and PU |
Klek et al., 2008 [36] | Poland | Gastrectomy or pancreaticoduodenectomy (n = 205) | PN | SO/MCT/FO (plus glutamine) (FO: 0.10 g/kg/day; % DLD not available) | SO/MCT | Mortality, infections, HLOS, and sepsis | – |
Klek et al., 2011 [37] | Poland | Gastrectomy or pancreaticoduodenectomy (n = 167) | PN | SO/MCT/FO (plus glutamine) (FO: 0.10 g/kg/day; % DLD not available) | SO/MCT | Mortality, infections, and sepsis | – |
Koller et al., 2003 [38] | Germany | Major abdominal surgery (n = 30) | total | SO/MCT/FO (FO: 0.07–0.14 g/kg/day; 10% DLD) | SO | – | LTB4, LTB5, and LTB ratio |
Liang et al., 2008 [39] | China | Radical colorectal cancer resection (n = 41) | total | SO/FO (FO: 0.20 g/kg/day; 17% DLD) | SO | Mortality, infection, and HLOS | GGT, IL-6, Plt, and TNF |
Linseisen et al., 2000 [40] | Germany | Major abdominal surgery (n = 33) | total | SO/MCT/FO(FO: 0.14 g/kg/day; 10% DLD) | SO | – | alpha-T, DHA, and EPA |
Ma et al., 2012 [41] | Taiwan | Gastrointestinal tumor surgery (n = 40) | PN | SO/MCT/OO/FO (FO: 0.15–0.30 g/kg/day; 15% DLD) | SO/MCT | HLOS | ALT, AST, bilirubin, Cr, CRP, IL-6, PU, TG, and TNF |
Ma et al., 2015 [42] | Taiwan | Gastric and colorectal cancer surgery (n = 99) | PN | SO/MCT/FO (FO: 0.08–0.15 g/kg/day; 10% DLD) | SO/MCT | Infections | ALT, AST, bilirubin, CRP, GGT, IL-6, TG, and TNF |
Makay et al., 2011 [43] | Turkey | Major gastric cancer surgery (n = 26) | PN | SO/FO (FO: 0.2 g/kg/day; 25% DLD) | SO | Mortality, infections, and HLOS | ALT, AST, Cr, and PU |
Mertes et al., 2006 [44] | European—Multicenter | Abdominal or thoracic surgery (n = 249) | total | SO/MCT/OO/FO (FO: 0.23 g/kg/day; 15% DLD) | SO | Mortality and HLOS | ALT, AST, bilirubin, GGT, and TG |
Schauder et al., 2002 [45] | Germany | Large bowel surgery (n = 60) | total | SO/FO (FO: 0.2 g/kg/day; 17% DLD | SO | – | TNF |
Senkal et al., 2007 [46] | Germany | Colorectal surgery (n = 40, received study treatments) | total | SO/MCT/FO (FO: 0.14–0.28 g/kg/day; 10% DLD) | SO/MCT | Infections | DHA, EPA |
Wang et al., 2012 [47] | China | Gastrointestinal surgery (n = 64) | total | SO/MCT/FO (FO: 0.04–0.08 g/kg/day; 10% DLD) | SO/MCT | Infections and sepsis | ALT, AST, bilirubin, CRP, GGT, IL-6, LTB ratio, Plt, TG, and TNF |
Wei et al., 2014 [48] | China | Surgical resection of gastric tumors (n = 52) | total | SO/FO (FO dose not available; 20% DLD) | SO | Infections | CRP, IL-6, and TNF |
Wu et al., 2014 [49] | Taiwan | Gastrointestinal surgery (n = 40) | PN | SO/MCT/OO/FO (FO 0.13 g/kg/day; 15% DLD) | SO/MCT | Infections and HLOS | ALT, AST, bilirubin, Cr, CRP, GGT, IL-6, PU, TG, and TNF |
Zhang et al., 2017 [50] | China | Hepatectomy (n = 320) | PN | SO/MCT/FO (FO dose not available; % DLD not available) | SO/MCT | Mortality, infections, HLOS, and sepsis | ALT, bilirubin, Cr, CRP, TG, Plt, and PU |
Zhixue et al., 2018 [51] | China | Liver cancer surgery (n = 75) | PN | SO/MCT/FO (FO dose not available; % DLD not available) | SO/MCT | – | IL-6 and TNF |
Zhu et al., 2012 [52] | China | Colorectal cancer surgery (n = 57, completed trial) | total | SO/FO (FO: 0.2 g/kg/day; 17% DLD) | SO | Infection, HLOS, and sepsis | IL-6 and TNF |
Zhu et al., 2013 [53] | China | Pancreaticoduodenectomy (n = 76) | total | SO/MCT/FO (FO: 0.2 g/kg/day; 18% DLD) | SO/MCT | Mortality, infection, HLOS, and hospital readmission | ALT, AST, and bilirubin |
Country | Cost Type | PN Containing Fish Oil (€) | Standard PN (€) | Difference (€) | ICER |
---|---|---|---|---|---|
France | Ward cost | 10,054 | 11,617 | −1563 | |
Infection cost | 166 | 264 | −98 | ||
Treatment cost | 179 | 181 | −2 | ||
Total | 10,399 | 12,061 | −1662 | dominant | |
Germany | Ward cost | 7444 | 8601 | −1157 | |
Infection cost | 286 | 455 | −169 | ||
Treatment cost | 580 | 687 | −107 | ||
Total | 8310 | 9743 | −1433 | dominant | |
Italy | Ward cost | 8369 | 9670 | −1301 | |
Infection cost | 265 | 421 | −156 | ||
Treatment cost | 409 | 693 | −284 | ||
Total | 9043 | 10,784 | −1741 | dominant | |
Spain | Ward cost | 7807 | 9020 | −1213 | |
Infection cost | 298 | 473 | −175 | ||
Treatment cost | 88 | 150 | −62 | ||
Total | 8192 | 9643 | −1451 | dominant | |
UK | Ward cost | 12,309 | 14,223 | −1914 | |
Infection cost | 125 | 198 | −73 | ||
Treatment cost | 327 | 386 | −59 | ||
Total | 12,761 | 14,807 | −2046 | dominant |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pradelli, L.; Heller, A.R.; Klek, S.; Mayer, K.; Rosenthal, M.D.; Muscaritoli, M. Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis. Nutrients 2025, 17, 1284. https://doi.org/10.3390/nu17071284
Pradelli L, Heller AR, Klek S, Mayer K, Rosenthal MD, Muscaritoli M. Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis. Nutrients. 2025; 17(7):1284. https://doi.org/10.3390/nu17071284
Chicago/Turabian StylePradelli, Lorenzo, Axel Rüdiger Heller, Stanislaw Klek, Konstantin Mayer, Martin D. Rosenthal, and Maurizio Muscaritoli. 2025. "Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis" Nutrients 17, no. 7: 1284. https://doi.org/10.3390/nu17071284
APA StylePradelli, L., Heller, A. R., Klek, S., Mayer, K., Rosenthal, M. D., & Muscaritoli, M. (2025). Parenteral Nutrition Containing Fish Oil for Hospitalized Non-Intensive Care Unit (ICU) Patients: A Systematic Review, Meta-Analysis, and Cost-Effectiveness Analysis. Nutrients, 17(7), 1284. https://doi.org/10.3390/nu17071284